Literature DB >> 14988239

Leptin resistance and enhancement of feeding facilitation by melanin-concentrating hormone in mice lacking bombesin receptor subtype-3.

Fumihiko Maekawa1, Hun-Meng A Quah, Kohichi Tanaka, Hiroko Ohki-Hamazaki.   

Abstract

Mice lacking either bombesin receptor subtype (BRS)-3 or gastrin-releasing peptide receptor (GRP-R) exhibit feeding abnormalities. However, it is unclear how these receptors are associated with feeding regulation. In BRS-3-deficient mice, we found hyperphagia, subsequent hyperleptinemia, and brain leptin resistance that occurred after the onset of obesity. To explore the cause of this phenomenon, we examined changes in feeding responses to appetite-related neuropeptides in BRS-3-deficient, GRP-R-deficient, and wild-type littermate mice. Among orexigenic neuropeptides, the hyperphagic response to melanin-concentrating hormone (MCH) was significantly enhanced in BRS-3-deficient mice but not in GRP-R-deficient mice. In addition, the levels of MCH-R and prepro-MCH mRNAs in the hypothalamus of BRS-3-deficient mice were significantly more elevated than those of wild-type littermates. There was no significant difference in feeding between BRS-3-deficient and wild-type littermate mice after treatment with bombesin (BN), although the hypophagic response to low-dose BN was significantly suppressed in the GRP-R-deficient mice. These results suggest that upregulation of MCH-R and MCH triggers hyperphagia in BRS-3-deficient mice. From these results, we assume that the BRS-3 gene deletion upsets the mechanism by which leptin decreases the expression of MCH-R and that this effect may be mediated through neural networks independent of BN-related peptides such as GRP-R.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988239     DOI: 10.2337/diabetes.53.3.570

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

Review 1.  Insights into bombesin receptors and ligands: Highlighting recent advances.

Authors:  Irene Ramos-Álvarez; Paola Moreno; Samuel A Mantey; Taichi Nakamura; Bernardo Nuche-Berenguer; Terry W Moody; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2015-05-11       Impact factor: 3.750

Review 2.  Bombesin receptor subtype 3 as a potential target for obesity and diabetes.

Authors:  Nieves González; Paola Moreno; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2015-06-12       Impact factor: 6.902

3.  A selective human bombesin receptor subtype-3 peptide agonist mediates CREB phosphorylation and transactivation.

Authors:  Xiaoqun Qin; Xiangping Qu; David Coy; H Christian Weber
Journal:  J Mol Neurosci       Date:  2011-11-30       Impact factor: 3.444

4.  Factors contributing to obesity in bombesin receptor subtype-3-deficient mice.

Authors:  Ellen E Ladenheim; Nahketah L Hamilton; Robert R Behles; Sheng Bi; Lori L Hampton; James F Battey; Timothy H Moran
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

5.  Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.

Authors:  Paola Moreno; Samuel A Mantey; Bernardo Nuche-Berenguer; Marc L Reitman; Nieves González; David H Coy; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2013-07-26       Impact factor: 4.030

Review 6.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

7.  Bombesin receptor subtype-3-expressing neurons regulate energy homeostasis through a novel neuronal pathway in the hypothalamus.

Authors:  Minoru Maruyama; Natsu Hotta; Yasunori Nio; Kenichi Hamagami; Toshimi Nagi; Masaaki Funata; Junichi Sakamoto; Masanori Nakakariya; Nobuyuki Amano; Mayumi Nishida; Tomohiro Okawa; Yasuyoshi Arikawa; Shinobu Sasaki; Shizuo Kasai; Yasutaka Nagisa; Yugo Habata; Masaaki Mori
Journal:  Brain Behav       Date:  2017-12-15       Impact factor: 2.708

8.  High-Throughput Screening of Mouse Gene Knockouts Identifies Established and Novel High Body Fat Phenotypes.

Authors:  David R Powell; Jean-Pierre Revelli; Deon D Doree; Christopher M DaCosta; Urvi Desai; Melanie K Shadoan; Lawrence Rodriguez; Michael Mullens; Qi M Yang; Zhi-Ming Ding; Laura L Kirkpatrick; Peter Vogel; Brian Zambrowicz; Arthur T Sands; Kenneth A Platt; Gwenn M Hansen; Robert Brommage
Journal:  Diabetes Metab Syndr Obes       Date:  2021-08-28       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.